Ergoteles LLC Acumen Pharmaceuticals, Inc. Transaction History
Ergoteles LLC
- $68.2 Billion
- Q3 2023
Shares
3 transactions
Others Institutions Holding ABOS
# of Institutions
82Shares Held
41.5MCall Options Held
2.9KPut Options Held
761K-
Ra Capital Management, L.P. Boston, MA14.9MShares$21.7 Million0.42% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$4.95 Million2.23% of portfolio
-
Franklin Resources Inc San Mateo, CA3.27MShares$4.75 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$3.13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.81 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $58.7M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...